Patient Leaflets
Summaries of medicine characteristics
Active substances
ATC codes
MENU
Patient Leaflets
Summaries of medicine characteristics
Active substances
ATC codes
Patient info
»
Patient leaflets
»
Lartruvo - patient leaflet, side effects, dosage
Lartruvo - patient leaflet, side effects, dosage
Contains active substance :
Olaratumab ()
ATC code:
L01XC27 olaratumab
Dostupné balení:
Patient leaflet
Summary of medicine characteristics
Patient leaflet - Lartruvo
Sources:
Original PDF (ema.europa.eu)
